Skip to content
Recall Observatory FDA recall evidence

Drug product

PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com

D-0084-2025

November 04, 2024

Class I

Product summary

Firm
Boulla LLC
Event
Event 95714
Status
Ongoing
Classification
Class I
Quantity
Unknown
Official record key
drug-enforcement:D-0084-2025

Official wording

Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Code information: Lot #: 230811, Exp: 08/11/2025

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.